Background Universal health coverage (UHC) aims to provide quality healthcare services and safeguard the population from the fnancial burden of catastrophic health expenditure. Its primary objectives are to improve longevity and enhance overall quality of life. This study investigates the...

Die Pflegeversicherung steht unter finanziellem Druck: In den vergangenen Jahren wurden die Leistungen durch mehrere Reformen erheblich ausgeweitet. Die Leistungsausweitung zeigte sowohl bei der sozialen als auch bei der privaten Pflegeversicherung Folgen. Bei der sozialen Pflegeversicherung war...

Durch die Corona-Pandemie haben digitale Technologien in Unternehmen an Bedeutung gewonnen. Auf Basis einer Betriebsbefragung des Instituts für Arbeitsmarkt- und Berufsforschung untersuchen die Autor:innen, ob Unternehmen vermehrt in digitale Technologien investiert haben und welche Rolle dabei...

In the programming period 2007-2013, the European Structural and Investment Fund (ESIF) invested €237 million in Slovak hospitals. We investigate whether this injection of additional funds has improved the quality of healthcare in the targeted hospitals. As a measure of quality, we use the...

Das Coronavirus hat die Weltwirtschaft in eine Krise gestürzt. Seit Anfang März 2020 wurden in Deutschland Kontakt- und Ausgangsbeschränkungen sowie Verbote der Geschäftstätigkeit verhängt, die Schul- und Kitabetreuung ausgesetzt und strenge Hygienevorgaben erlassen. Daraufhin hat sich die...

We assess the impact of the timing of lockdown measures implemented in Germany and Switzerland on cumulative COVID-19-related hospitalization and death rates. Our analysis exploits the fact that the epidemic was more advanced in some regions than in others when certain lockdown measures came...

The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines Agency (EMA) search engine showed 54 authorized biosimilars. Biosimilars...

This article sheds light on the role of subnational governments in health systems across OECD countries. The views in this article show a move away from traditional measures of decentralisation, such as the share of subnational government expenditure of total expenditure, to measures capturing a...

This article presents the main findings of two OECD Surveys of Senior Budget and Health Officials conducted in the Latin American and Caribbean region. The surveys help to understand the approaches to budgeting, and take account of the prominent role of agents in the health system across the...

This article presents the findings of the OECD Survey of Senior Budget Officials on Budgeting Practices from a 2017 survey covering the Asia and Oceania, and Central, Eastern and South Eastern European regions. The survey is part of the ongoing engagement between health and budget officials in...